[
    [
        {
            "time": "",
            "original_text": "长春高新上半年疫苗板块下滑明显，净利润同比下降30.8% 盈利能力下降",
            "features": {
                "keywords": [
                    "长春高新",
                    "疫苗",
                    "板块下滑",
                    "净利润下降",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "长春高新上半年疫苗板块下滑明显，净利润同比下降30.8% 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "长春高新: 生长激素业务持续快速增长, 疫苗下半年有望重回正轨",
            "features": {
                "keywords": [
                    "长春高新",
                    "生长激素",
                    "业务增长",
                    "疫苗",
                    "下半年正轨"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "生长激素",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新: 生长激素业务持续快速增长, 疫苗下半年有望重回正轨",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]